These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18930283)

  • 1. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.
    Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson JE; Hugosson J;
    J Urol; 2008 Dec; 180(6):2423-9; discussion 2429-30. PubMed ID: 18930283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.
    Holmström B; Holmberg E; Egevad L; Adolfsson J; Johansson JE; Hugosson J; Stattin P;
    J Urol; 2010 Oct; 184(4):1322-7. PubMed ID: 20723940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen velocity in untreated, localized prostate cancer.
    Venkitaraman R; Norman A; Woode-Amissah R; Dearnaley D; Horwich A; Huddart R; Parker C
    BJU Int; 2008 Jan; 101(2):161-4. PubMed ID: 17850368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of men with clinically localized prostate cancer who deferred definitive therapy.
    Patel MI; DeConcini DT; Lopez-Corona E; Ohori M; Wheeler T; Scardino PT
    J Urol; 2004 Apr; 171(4):1520-4. PubMed ID: 15017211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
    Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
    J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in younger men following permanent prostate brachytherapy.
    Shapiro EY; Rais-Bahrami S; Morgenstern C; Napolitano B; Richstone L; Potters L
    J Urol; 2009 Apr; 181(4):1665-71; discussion 1671. PubMed ID: 19233394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
    Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
    Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
    J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing prostate specific antigen triggers for intervention in men with stable prostate cancer on active surveillance.
    Loblaw A; Zhang L; Lam A; Nam R; Mamedov A; Vesprini D; Klotz L
    J Urol; 2010 Nov; 184(5):1942-6. PubMed ID: 20846681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
    Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
    Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
    Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
    J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age.
    Grönberg H; Damber L; Jonson H; Damber JE
    Urology; 1997 Mar; 49(3):374-8. PubMed ID: 9123701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series.
    Adolfsson J; Steineck G; Hedlund PO
    Urology; 1997 Nov; 50(5):722-6. PubMed ID: 9372882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.
    Latini DM; Hart SL; Knight SJ; Cowan JE; Ross PL; Duchane J; Carroll PR;
    J Urol; 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. PubMed ID: 17632144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup.
    Adolfsson J; Steineck G; Hedlund PO
    J Urol; 1999 Feb; 161(2):505-8. PubMed ID: 9915436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.